Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edward Fox, MD, PhD
Central Texas Neurology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tg Therapeutics Investigational Trial Site
Phoenix, Arizona, United States
- Tg Therapeutics Investigational Trial Site
Pasadena, California, United States
- Tg Therapeutics Investigational Trial Site
Torrance, California, United States
- Tg Therapeutics Investigational Trial Site
Aurora, Colorado, United States
- Tg Therapeutics Investigational Trial Site
Fort Collins, Colorado, United States
- Tg Therapeutics Investigational Trial Site
Lexington, Kentucky, United States
- Tg Therapeutics Investigational Trial Site
Teaneck, New Jersey, United States
- Tg Therapeutics Investigational Trial Site
Akron, Ohio, United States
- Tg Therapeutics Investigational Trial Site
Columbus, Ohio, United States
- Tg Therapeutics Investigational Trial Site
Knoxville, Tennessee, United States
- Tg Therapeutics Investigational Trial Site
Round Rock, Texas, United States
- Tg Therapeutics Investigational Trial Site
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 May 2016
- Primary completion
- 27 Sept 2017
- Completion
- 13 Aug 2018
- Last update posted
- 15 Jul 2021
- Registered enrollment
- 49
- Registry id
- NCT02738775
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.